We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ribose and Sport Performance

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01727479
First Posted: November 16, 2012
Last Update Posted: December 5, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Atrium Innovations
Information provided by (Responsible Party):
Laval University
  Purpose
Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Condition Intervention
Sports Other: Ribose Other: Placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: The Effect of Ribose on Performance and Recovery in Athletes

Further study details as provided by Laval University:

Primary Outcome Measures:
  • Change in time to complete the third of 3 consecutive 3km time trials on bike [ Time Frame: baseline and 1 week ]

Secondary Outcome Measures:
  • Performance on the 3 consecutive 3km time trials on bike [ Time Frame: baseline and 1 week ]
    Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)


Other Outcome Measures:
  • Fatigue perception after each of the 3 consecutive 3km time trials on bike [ Time Frame: baseline and 1 week ]
    Post-exercise fatigue perception on visual analog scale (VAS)

  • Peak Vo2 consumption during each of the 3km time trials on bike [ Time Frame: baseline and 1 week ]

Enrollment: 18
Study Start Date: August 2012
Study Completion Date: January 2013
Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Ribose
After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.
Other: Ribose
After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.
Placebo Comparator: Placebo
After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.
Other: Placebo

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men and women
  • Training volume > 7hrs/week
  • VO2 max > 40 and 45 mg/kg/min (for women and men respectively)
  • Otherwise healthy individuals

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia
  • Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders
  • Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01727479


Locations
Canada, Quebec
Université Laval
Québec, Quebec, Canada, G1V0A6
Sponsors and Collaborators
Laval University
Atrium Innovations
Investigators
Principal Investigator: Benoît Lamarche, PhD Institute on nutraceuticals and functional foods
  More Information

Responsible Party: Laval University
ClinicalTrials.gov Identifier: NCT01727479     History of Changes
Other Study ID Numbers: 2012-048
INAF-2012-048
First Submitted: November 2, 2012
First Posted: November 16, 2012
Last Update Posted: December 5, 2016
Last Verified: December 2016

Keywords provided by Laval University:
Peak VO2 consumption
3km time trial
fatigue perception
lactate
time to complete